Akèy › Ipertiwoïdism
Etid klinik pou Ipertiwoïdism ap rekrite nan Etazini
9 etid pou Ipertiwoïdism ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Dallas, TX5 etid
- Miami, FL5 etid
- San Antonio, TX4 etid
- Houston, TX4 etid
- Akron, OH3 etid
- Asheville, NC3 etid
- San Francisco, CA3 etid
- Torrance, CA3 etid
Pa eta
- Arizona4 etid
- Florid6 etid
- Georgia4 etid
- Kalifòni7 etid
- Michigan3 etid
- New York3 etid
- North Carolina6 etid
- Ohio4 etid
- Pennsylvania3 etid
- Tennessee3 etid
- Texas6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Oct 1, 2026 · NCT07661056NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07305818Natural History of Thyroid Function Disorders
Ap rekriteEtid obsèvasyon
6 Months – 98 Years · Tout sèks · Mizajou Sep 16, 2026 · NCT00001159A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07722546Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 25, 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jul 31, 2026 · NCT06980649Evaluating an AI Tool for Detecting Thyrotoxic States
Ap rekriteEtid obsèvasyon
Laj 22 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT07017907Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
Ap rekriteFaz 2
Laj 9 a 17 · Tout sèks · Mizajou Jan 27, 2026 · NCT07369063Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.